Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celecoxib effect on efficacy and safety of amlodipine in hypertension
2013-005381-19Phase 3Completed
- Sponsor
- Purple Biotech Ltd.
- Start
- May 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in hypertension (HTN) comparing amlodipine + celecoxib with amlodipine + placebo (celecoxib placebo) (2 arms). Primary endpoint: Change in average daytime ambulatory systolic blood pressure (SBPday). Started May 2014; status: completed.
02
Drugs
celecoxib
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on 2013-005381-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-005381-19.